The Cambridge BRC already has strong links with industry. Jointly funded projects include those below.
GSK Clinical Unit Cambridge
Cambridge BRC have been fortunate to collaborate with industry in an innovative and productive manner since 1999 with the co-location of GlaxoSmithKline's Clinical Unit Cambridge on the BRC site. This Phase 1/2 unit allows the BRC to perform unique translational studies in healthy volunteers and patients, thereby highlighting the benefits of close interaction between the academic community and industry in bringing new drugs for patient benefit.
A new PET/CT scanning department ' one of only a handful in the UK, and the first in East Anglia ' opened in December 2008.
The department is the result of a collaboration between the Cambridge Biomedical Research Centre, Merck Sharp & Dohme (MSD), Cancer Research UK, Addenbrooke's and the University of Cambridge.
NIHR BRC & GSK linked Translational Medicine Research Fellowships
Several Trust Fellowships posts are joint funded by GSK.
This ground-breaking new concept will tap into the highest quality thinking in academia to optimise the early clinical development of new GlaxoSmithKline medicines in a model of shared risk and reward.
If your company is interested in collaborating with the Cambridge BRC please see the contact pages for the individual themes.